The immunoinhibitory and immunostimulatory effects of hydroxyanthra- and hydroxynaphthoquinone derivatives
Language English Country United States Media print
Document type Journal Article
PubMed
7196864
DOI
10.1007/bf02927418
Knihovny.cz E-resources
- MeSH
- Adjuvants, Immunologic pharmacology MeSH
- Anthraquinones pharmacology MeSH
- Antibody-Producing Cells drug effects MeSH
- Erythrocytes immunology MeSH
- Immunosuppressive Agents pharmacology MeSH
- Cells, Cultured MeSH
- Naphthoquinones pharmacology MeSH
- Sheep MeSH
- Cell Count MeSH
- Spleen cytology immunology MeSH
- Antibody Formation drug effects MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Adjuvants, Immunologic MeSH
- Anthraquinones MeSH
- Immunosuppressive Agents MeSH
- Naphthoquinones MeSH
The immunostimulatory and immunoinhibitory effects of 44 hydroxyanthra- and hydroxynaphthoquinone derivatives in tissue culture were investigated. In the test system used, the final effect, i.e. production of antibodies against sheep red blood cells is a result of cooperation between macrophages, T lymphocytes and B lymphocytes. It was found when testing selected 20 derivatives that methylation, acetylation or substitution of the hydroxy group by the amino group led to the loss of the inhibitory activity and, on the contrary, pronounced immunostimulatory effects could be observed in other derivatives. Naphthoquinones (juglone, lawsone) were more effective as immunoinhibitors than anthraquinones (alizarin, quinizarin) and their derivatives. In both groups of compounds glucosidation results in a substantial increase of the immunoinhibitory effect. The present work is a part of a more extensive study concerning modification of the molecules of various compounds and its relationship with the effect on immunological reactions.
See more in PubMed
Acta Microbiol Acad Sci Hung. 1955;3(1-2):191-202 PubMed
Science. 1959 Aug 21;130(3373):432-7 PubMed
C R Hebd Seances Acad Sci. 1963 Jun 5;256:5005-8 PubMed
Folia Microbiol (Praha). 1963;40:376-7 PubMed
Immunology. 1964 Jan;7:65-71 PubMed
Folia Microbiol (Praha). 1964 May;14:173-6 PubMed
Biochim Biophys Acta. 1965 May 11;103:25-49 PubMed
Cancer Res. 1978 Dec;38(12):4377-84 PubMed
Lancet. 1967 Dec 16;2(7529):1279-81 PubMed
Adv Immunol. 1972;15:95-165 PubMed
N Engl J Med. 1979 Jun 14;300(24):1392 PubMed
Naturwissenschaften. 1979 Apr;66(4):173-81 PubMed
Cancer Chemother Rep 2. 1974 Apr;4(2):1-362 PubMed
Cancer Chemother Pharmacol. 1979;2(1):25-30 PubMed
Br J Pharmacol. 1970 Dec;40(4):871-80 PubMed
Proc Soc Exp Biol Med. 1969 Jan;130(1):305-10 PubMed
Cancer Res. 1969 Aug;29(8):1507-11 PubMed
J Med Chem. 1978 Mar;21(3):291-4 PubMed
J Med Chem. 1978 Apr;21(4):369-74 PubMed
Nouv Presse Med. 1978 Jun 10;7(23):2061-6 PubMed
Folia Microbiol (Praha). 1976;21(1):54-7 PubMed
Folia Biol (Praha). 1977;23(2):99-109 PubMed
J Antimicrob Chemother. 1977 Mar;3(2):133-9 PubMed
Microbial glucosidation of 1,2,4-trihydroxy-9,10-anthraquinone (purpurin)
Effect of colchicine derivatives on the antibody response induced in vitro